뒤로
Lantheus Holdings Inc(LNTH) 가격
LNTH 주가 차트
LNTH 수입
Lantheus Holdings Inc
$67.28
0.16%
$0.1
종가: Feb 11, 16:00:00 GMT-5
$67.28
0%
$0
애프터마켓: Feb 11, 20:00:00 GMT-5
최신 수익 결과: Q3 '25
보고됨: 2025-11-06
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
LNTH의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Lantheus Holdings Inc LNTH의 지난 분기 매출 실적은 어땠나요?
Lantheus Holdings Inc의 매출 추정치는 얼마인가요?
Lantheus Holdings Inc의 수익 품질 점수는 얼마인가요?
Lantheus Holdings Inc는 언제 수익을 보고하나요?
Lantheus Holdings Inc의 예상 수익은 얼마인가요?
Lantheus Holdings Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$67.17
시가
$67.1
일일 범위
$64.52 - $67.58
52주 범위
$47.25 - $111.29
거래량
965.1K
평균 거래량
985.0K
EPS(TTM)
2.38
배당수익률
--
시가총액
$4.4B
LNTH란 무엇인가요?
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 808 full-time employees. The company went IPO on 2015-06-25. The firm's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The firm's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The firm's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The firm's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.